Israel's Ocular discovery partners with all India Institute of Medical Sciences
Ocular Discovery and AIIMSsigned a novel research partnership investigating the mechanism of action of Dipyridamole, for optimized delivery and therapeutic treatment of various Ocular Surface Disorders.
Novartis acquires full rights to IFM Tre's portfolio of NLRP3 inhibitors
Preclinical studies have shown that IFM Tre's molecules can selectively suppress inflammation caused by the NLRP3 inflammasome while allowing the rest of the immune system to continue normal operations.
AstraZeneca, Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate
Trastuzumab deruxtecan is currently in development for the treatment of multipleHER2-expressing cancers, including breast and gastric cancer, and in patients withHER2-low expression.
CDC modifies advisory against travelling to India based on Zika Virus status; ICMR furthers Zika virus study
The Indian Government had urged the US to withdraw or modify its advisory in January by providing evidence of the contained Zika Virus outbreak in the country.